Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Raltitrexed for Injection

Approval Number

国药准字H20213097

Company扬子江药业集团有限公司

Registration Date

February 2, 2021

Drug Information

Generic Name

注射用雷替曲塞

Dosage Form

注射剂

Strength

2mg

Drug Type

化学药品

Registration Date

February 2, 2021

Company Information

Applicant Company

Company Name扬子江药业集团有限公司

Company Address

江苏省泰州市扬子江南路1号

Manufacturing Company

Company Name扬子江药业集团有限公司

Company Address

江苏省泰州市扬子江南路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用雷替曲塞 - NMPA 批准文号 | MedPath